JP Morgan analyst Anupam Rama upgrades Solid Biosciences (NASDAQ:SLDB) from Underweight to Neutral.
Piper Sandler Maintains Neutral on ChargePoint Hldgs, Lowers Price Target to $13
Piper Sandler analyst Kashy Harrison maintains ChargePoint Hldgs (NYSE:CHPT) with a Neutral and lowers the price target from $16 to $13.